Cao J - Search Results

1

Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia.

Zheng Q, Cao J, Hamad N, Kim HJ, Moon JH, Sohn SK, Jung CW, Lipton JH, Kim DD. Zheng Q, et al. Among authors: cao j. J Transl Med. 2016 Mar 24;14:82. doi: 10.1186/s12967-016-0837-5. J Transl Med. 2016. PMID: 27009330 Free PMC article.

2

Association between mitogen-activated protein kinase kinase kinase 1 polymorphisms and breast cancer susceptibility: a meta-analysis of 20 case-control studies.

Zheng Q, Ye J, Wu H, Yu Q, Cao J. Zheng Q, et al. Among authors: cao j. PLoS One. 2014 Mar 4;9(3):e90771. doi: 10.1371/journal.pone.0090771. eCollection 2014. PLoS One. 2014. PMID: 24595411 Free PMC article.

3

Translational regulator eIF2α in tumor.

Zheng Q, Ye J, Cao J. Zheng Q, et al. Among authors: cao j. Tumour Biol. 2014 Jul;35(7):6255-64. doi: 10.1007/s13277-014-1789-0. Epub 2014 Mar 9. Tumour Biol. 2014. PMID: 24609900 Review.

4

Hepatocyte growth factor activator inhibitor type‑1 in cancer: advances and perspectives (Review).

Zheng Q, Wu H, Cao J, Ye J. Zheng Q, et al. Among authors: cao j. Mol Med Rep. 2014 Dec;10(6):2779-85. doi: 10.3892/mmr.2014.2628. Epub 2014 Oct 13. Mol Med Rep. 2014. PMID: 25310042 Review.

5

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma.

Liu H, Wei Q, Wang J, Huang X, Li C, Zheng Q, Cao J, Jia Z. Liu H, et al. Among authors: cao j. BMC Cancer. 2015 Apr 29;15:325. doi: 10.1186/s12885-015-1339-1. BMC Cancer. 2015. PMID: 25924900 Free PMC article.

6

Circulating adiponectin and risk of endometrial cancer.

Zheng Q, Wu H, Cao J. Zheng Q, et al. Among authors: cao j. PLoS One. 2015 Jun 1;10(6):e0129824. doi: 10.1371/journal.pone.0129824. eCollection 2015. PLoS One. 2015. PMID: 26030130 Free PMC article.

7

Nuclear distribution of eIF3g and its interacting nuclear proteins in breast cancer cells.

Zheng Q, Liu H, Ye J, Zhang H, Jia Z, Cao J. Zheng Q, et al. Among authors: cao j. Mol Med Rep. 2016 Apr;13(4):2973-80. doi: 10.3892/mmr.2016.4935. Epub 2016 Feb 23. Mol Med Rep. 2016. PMID: 26935993 Free PMC article.

8

MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.

Yang C, Shao T, Zhang H, Zhang N, Shi X, Liu X, Yao Y, Xu L, Zhu S, Cao J, Cheng H, Yan Z, Li Z, Niu M, Xu K. Yang C, et al. Among authors: cao j. J Transl Med. 2018 Oct 1;16(1):267. doi: 10.1186/s12967-018-1647-8. J Transl Med. 2018. PMID: 30285885 Free PMC article.

9

High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.

Zhang H, Zhang N, Wang R, Shao T, Feng Y, Yao Y, Wu Q, Zhu S, Cao J, Zhang H, Li Z, Liu X, Niu M, Xu K. Zhang H, et al. Among authors: cao j. J Transl Med. 2019 Apr 1;17(1):106. doi: 10.1186/s12967-019-1858-7. J Transl Med. 2019. PMID: 30935386 Free PMC article.

10

Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study.

Zhu F, Wang Y, Zeng S, Fu X, Wang L, Cao J. Zhu F, et al. Among authors: cao j. OMICS. 2009 Dec;13(6):467-76. doi: 10.1089/omi.2009.0046. OMICS. 2009. PMID: 20001861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,899 results

Search Page

Filters